Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
15th July 2016
How Bioresorbable Vascular Can Be Beneficial for Patients in the Long-Term
Coronary artery disease (CAD) is the leading cause of mortality in patients ≥60 years old worldwide, and may result in stable angina, acute coronary…
3
Mins
14th July 2016
Zika Experts: Varied Neurological Complications, Virus Still Detectable After Recovery
London, 14 July, 2016 – The International Congress on Neuromuscular Diseases (ICND) just drew to an end in Toronto. Among the many questions addressed…
4
Mins
13th July 2016
U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets Intended to Treat Soil-Transmitted Helminthiasis
Janssen Pharmaceuticals, Inc. announced that the U.S. FDA has granted Priority Review designation for the New Drug Application for a 500mg chewable tablet formulation of mebendazole
2
Mins
12th July 2016
Introducing EMJ Neurology 4.1
Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…
3
Mins
12th July 2016
A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes
Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…
16
Mins
12th July 2016
Review of the 2nd European Academy of Neurology Congress 2016
Although history and tradition are hallmarks of Danish culture, recent developments have created a hub of modern Danish trademarks in Copenhagen. Hosted…
July 2016
EMJ Neurology 4.1 2016
Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…
12th July 2016
Brain Health: Translating Scientific Evidence Into Clinical Practice in Multiple Sclerosis
Brain volume loss (BVL) progresses more rapidly in patients with multiple sclerosis (MS) than in healthy individuals, and brain atrophy begins early in…
12th July 2016
Editor’s Pick: Clinical Significance of Apathy in Parkinson’s Disease
Apathy, or lack of motivation, is increasingly recognised as a major factor affecting quality of life and prognosis in Parkinson’s disease (PD)…
12th July 2016
Development and Translation of Therapies for Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder characterised by widespread loss of lower motor neurons from the spinal…
←
1
2
3
…
756
757
758
759
760
761
762
…
897
898
899
→